Highlights Carl Zeiss Meditec AG

Equities

AFX

DE0005313704

Market Closed - Xetra Other stock markets 16:35:26 07/05/2024 BST			5-day change	1st Jan Change
99.65 ^EUR	-0.35%		+0.55%	+0.82%

04-24	CARL ZEISS MEDITEC AG : Gets a Buy rating from UBS	ZD
04-23	CARL ZEISS MEDITEC AG : Receives a Sell rating from JP Morgan	ZD

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CARL ZEISS MEDITEC : Potential remains intact, despite some near-term jitters	04-18
Carl Zeiss Meditec expands ophthalmology portfolio through acquisition	04-04	DP
Eurazeo Completes Sale of Medical Device Company to Carl Zeiss Meditec	04-04	MT
Eurazeo: finalizes sale of DORC	04-03	CF
Carl Zeiss Meditec AG completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).	04-02	CI
Ex-dividend day for final dividend	03-21	FA
CARL ZEISS MEDITEC : Carl Zeiss Meditec’s re-rating journey should continue further	02-21
JPMorgan raises Carl Zeiss Meditec target to 59 euros - 'Underweight'	02-12	DP
ASML's next chip challenge: rollout of its new $350 million 'High NA EUV' machine	02-09	RE
CARL ZEISS MEDITEC : Despite the profitability miss, FY 23/24 guidance unchanged	02-09
Slow start for Carl Zeiss Meditec - shares nevertheless rise	02-09	DP
Carl Zeiss Meditec jumps up - figures better than feared	02-09	DP
European shares flat as higher yields counter earnings bump	02-09	RE
Carl Zeiss Meditec AG Provides Earnings Guidance for the Year 2024	02-09	CI
European shares inch up on earnings bump, higher yields weigh	02-09	RE
Mainz-based specialty glass manufacturer Schott presents balance sheet	01-31	DP
Carl Zeiss Meditec Board Approves EUR150 Million Share Buyback	01-29	MT
Medical technology group Carl Zeiss Meditec wants to buy back shares	01-29	DP
Carl Zeiss Meditec AG Reports Earnings Results for the First Quarter Ended December 31, 2023	01-14	CI
Carl Zeiss Meditec AG Announces U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS	01-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

CARL ZEISS MEDITEC : Potential remains intact, despite some near-term jitters

April 18, 2024 at 03:46 pm